Alnylam Pharmaceuticals | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Arrowhead Research USD 27.77M 514.94M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 14.84B 1.28B 2025-06
PTC Therapeutics USD 178.9M 11.1M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Sanofi EUR 10.74B 529.51M 2025-06
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Takeda JPY 1.11T 60B 2025-06
Tectonic Therapeutic 0 0 2024-12
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06
Xencor USD 43.61M 10.88M 2025-06


Alnylam Pharmaceuticals Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.